Which ETFs hold Astellas Pharma Inc (4503)?
Japanese pharmaceutical company focused on cancer, urology and other medicines.
30 Australian ETFs hold Astellas Pharma Inc, a Health Care company from Japan. HLTH has the biggest weighting at 2.10%. Across these funds, Australian ETF investors own about $44m of Astellas Pharma Inc.
The ETFs with the most Astellas Pharma Inc
All 30 ETFs that hold Astellas Pharma Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Astellas Pharma Inc.
Common questions
Which ETF has the most Astellas Pharma Inc?
HLTH (VanEck Global Healthcare Leaders ETF) has the highest weighting, with 2.10% of the fund in Astellas Pharma Inc.
What is the cheapest ETF that holds Astellas Pharma Inc?
Of the ETFs where Astellas Pharma Inc is at least 1% of the fund, HLTH has the lowest fee at 0.45% a year, with 2.10% in Astellas Pharma Inc.
How much Astellas Pharma Inc do I own with $10,000 in QUAL?
About $8. QUAL is the largest ETF that holds Astellas Pharma Inc, and Astellas Pharma Inc makes up 0.08% of it.
How many Australian ETFs hold Astellas Pharma Inc?
30 ETFs listed on the ASX or TMX Australia hold Astellas Pharma Inc, based on issuers' published holdings.